ConductScience.org, home

Paper9392001

Recent advances in the treatment of malignant melanoma with gene therapy.

Hersh EM and 1 other. Mol Med, 1997. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Recent advances in the treatment of malignant melanoma with gene therapy. Papers, record 9392001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9392001

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent advances in the treatment of malignant melanoma with gene therapy.
PubMed
Journal
Mol Med
PubMed
Year
1997
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.03
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hersh EME M
2Stopeck ATA T

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
MelanomaMajor topic
Cancer Vaccines
Clinical Trials as Topic
Gene Transfer Techniques
Humans

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19018235Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells.Nat Med1997https://conductscience.org/library/papers/9018235PubMed
29072306Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.Cancer J Sci Am1997https://conductscience.org/library/papers/9072306PubMed
39080123Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.Cancer Gene Ther1997https://conductscience.org/library/papers/9080123PubMed
49113517The TMC Worldwide Gene Therapy Enrollment Report, end 1996.Hum Gene Ther1997https://conductscience.org/library/papers/9113517PubMed
59274718Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.Gene Ther1997https://conductscience.org/library/papers/9274718PubMed
69815928Alterations in T cell receptor and signal transduction molecules in melanoma patients.Clin Cancer Res1995https://conductscience.org/library/papers/9815928PubMed
79816311Interleukin 10 production by human melanoma.Clin Cancer Res1996https://conductscience.org/library/papers/9816311PubMed
89816136Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.Clin Cancer Res1996https://conductscience.org/library/papers/9816136PubMed
99815709Decreased antigen presentation by dendritic cells in patients with breast cancer.Clin Cancer Res1997https://conductscience.org/library/papers/9815709PubMed
109166458The development of new cancer therapies based on the molecular identification of cancer regression antigens.Cancer J Sci Am1995https://conductscience.org/library/papers/9166458PubMed
117524733Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity.Blood1994https://conductscience.org/library/papers/7524733PubMed
127530375Retrovirus-mediated gene transfer in cancer therapy.Pharmacol Ther1994https://conductscience.org/library/papers/7530375PubMed
137833372Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.Hum Gene Ther1994https://conductscience.org/library/papers/7833372PubMed
147844602Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.J Clin Oncol1995https://conductscience.org/library/papers/7844602PubMed
157850546Cytokine-mediated gene therapy for cancer.Ann Surg Oncol1994https://conductscience.org/library/papers/7850546PubMed
167533326The Fas death factor.Science1995https://conductscience.org/library/papers/7533326PubMed
177879680Immunotherapy and gene therapy of cancer.Adv Surg1995https://conductscience.org/library/papers/7879680PubMed
187621248Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.Cancer Gene Ther1994https://conductscience.org/library/papers/7621248PubMed
198624371The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders.Ann Hematol1996https://conductscience.org/library/papers/8624371PubMed
208785710Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.Cancer Gene Ther1996https://conductscience.org/library/papers/8785710PubMed

See all 100 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9392001

GET https://conductscience.org/api/papers/v1/9392001/references?page=2